Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP167169.RAn8GjlMgAJqejk7VL2DekLIha-RpB6xN1LPdvhkUKGLU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP167169.RAn8GjlMgAJqejk7VL2DekLIha-RpB6xN1LPdvhkUKGLU130_assertion type Assertion NP167169.RAn8GjlMgAJqejk7VL2DekLIha-RpB6xN1LPdvhkUKGLU130_head.
- NP167169.RAn8GjlMgAJqejk7VL2DekLIha-RpB6xN1LPdvhkUKGLU130_assertion description "[The increased number of cells that expressed Oct4A in prostate cancer compared to benign prostate, and in cancers of increasing grade, suggests that Oct4A/Chromogranin A co-expressing cells represent neuroendocrine cells in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP167169.RAn8GjlMgAJqejk7VL2DekLIha-RpB6xN1LPdvhkUKGLU130_provenance.
- NP167169.RAn8GjlMgAJqejk7VL2DekLIha-RpB6xN1LPdvhkUKGLU130_assertion evidence source_evidence_literature NP167169.RAn8GjlMgAJqejk7VL2DekLIha-RpB6xN1LPdvhkUKGLU130_provenance.
- NP167169.RAn8GjlMgAJqejk7VL2DekLIha-RpB6xN1LPdvhkUKGLU130_assertion SIO_000772 19058139 NP167169.RAn8GjlMgAJqejk7VL2DekLIha-RpB6xN1LPdvhkUKGLU130_provenance.
- NP167169.RAn8GjlMgAJqejk7VL2DekLIha-RpB6xN1LPdvhkUKGLU130_assertion wasDerivedFrom lhgdn-20090331 NP167169.RAn8GjlMgAJqejk7VL2DekLIha-RpB6xN1LPdvhkUKGLU130_provenance.
- NP167169.RAn8GjlMgAJqejk7VL2DekLIha-RpB6xN1LPdvhkUKGLU130_assertion wasGeneratedBy ECO_0000203 NP167169.RAn8GjlMgAJqejk7VL2DekLIha-RpB6xN1LPdvhkUKGLU130_provenance.